Rick E Winningham

2016 - Theravance Biopharma

In 2016, Rick E Winningham earned a total compensation of $6.3M as Chief Executive Officer at Theravance Biopharma, a 14% increase compared to previous year.

Compensation breakdown

Bonus$189,744
Non-Equity Incentive Plan$433,702
Salary$903,545
Stock Awards$4,748,800
Other$5,000
Total$6,280,791

Winningham received $4.7M in stock awards, accounting for 76% of the total pay in 2016.

Winningham also received $189.7K in bonus, $433.7K in non-equity incentive plan, $903.5K in salary and $5K in other compensation.

Rankings

In 2016, Rick E Winningham's compensation ranked 1,112th out of 14,075 executives tracked by ExecPay. In other words, Winningham earned more than 92.1% of executives.

ClassificationRankingPercentile
All
1,112
out of 14,075
92nd
Division
Manufacturing
374
out of 5,488
93rd
Major group
Chemicals And Allied Products
99
out of 1,900
95th
Industry group
Drugs
65
out of 1,543
96th
Industry
Pharmaceutical Preparations
54
out of 1,173
95th
Source: SEC filing on March 21, 2018.

Winningham's colleagues

We found three more compensation records of executives who worked with Rick E Winningham at Theravance Biopharma in 2016.

2016

Bradford Shafer

Theravance Biopharma

General Counsel

2016

Frank Pasqualone

Theravance Biopharma

Senior Vice President and Global Head, Acute Care Business

2016

Renee Gala

Theravance Biopharma

Chief Financial Officer

News

You may also like